1. Inter-society consensus document on treatment and prevention of bronchiolitis in newborns and infants
- Author
-
Francesco Paravati, Giovanni A. Rossi, Roberto Bernardini, Marco Cappa, Gianpaolo Donzelli, Luigi Memo, Carlo Minetti, Giampietro Chiamenti, Filippo Festini, Andrea Biondi, Giuseppe Magazzù, Pierluigi Colonna, Silvia Vandini, Marcello Lanari, Carlo Catassi, Alessandro Rimini, Giovanni Corsello, Giuseppe Di Mauro, Susanna Esposito, Paolo Manzoni, Antonio Francesco Urbino, Marina Picca, Paolo Biban, Costantino Romagnoli, Eugenio Baraldi, Eugenio Baraldi, Marcello Lanari, Paolo Manzoni, Giovanni A Rossi, Silvia Vandini, Alessandro Rimini, Costantino Romagnoli, Pierluigi Colonna, Andrea Biondi, Paolo Biban, Giampietro Chiamenti, Roberto Bernardini, Marina Picca, Marco Cappa, Giuseppe Magazzù, Carlo Catassi, Antonio Urbino, Luigi Memo, Gianpaolo Donzelli, Carlo Minetti, Francesco Paravati, Giuseppe Di Mauro, Filippo Festini, Susanna Esposito, Giovanni Corsello, Baraldi, E, Lanari, M, Manzoni, P, Rossi, GA, Vandini, S, Rimini, A, Romagnoli, C, Colonna, P, Biondi, A, Biban, P, Chiamenti, G, Bernardini, R, Picca, M, Cappa, M, Magazzu, G, Catassi, C, Urbino, AF, Memo, L, Donzelli, G, Minetti, C, Paravati, F, Di Mauro, G, Festini, F, and Corsello, G
- Subjects
Pediatrics ,Bronchiolitis ,Bronchopulmonary dysplasia ,Congenital heart diseases ,Immunodeficiency ,Oxygen therapy ,Prematurity ,Prevention ,Prophylaxis ,Respiratory syncytial virus ,Review ,Severity of Illness Index ,Settore MED/38 - Pediatria Generale E Specialistica ,Adrenergic beta-2 Receptor Antagonists ,Vitamin D ,Children ,Respiratory distress ,Vitamins ,Environmental exposure ,Patient Discharge ,Anti-Bacterial Agents ,Bronchodilator Agents ,Hospitalization ,Settore MED/38 - PEDIATRIA GENERALE E SPECIALISTICA ,bronchiolitis ,medicine.drug ,Palivizumab ,Respiratory Therapy ,medicine.medical_specialty ,Epinephrine ,Decision Making ,Antibodies, Monoclonal, Humanized ,Antiviral Agents ,Intensive Care Units, Neonatal ,Bronchiolitis, Respiratory syncytial virus, Prematurity, Bronchopulmonary dysplasia, Congenital heart diseases, Immunodeficiency, Oxygen therapy, Prevention, Prophylaxis ,medicine ,Humans ,Acute bronchiolitis ,Medical history ,Consensus Document ,Intensive care medicine ,Glucocorticoids ,Asthma ,Saline Solution, Hypertonic ,Primary Health Care ,business.industry ,Nebulizers and Vaporizers ,Infant, Newborn ,Oxygen Inhalation Therapy ,Humidity ,Environmental Exposure ,Acute bronchiolitis, Consensus Document ,medicine.disease ,Hypertonic saline ,business - Abstract
Acute bronchiolitis is the leading cause of lower respiratory t ract infection and hospitalization in children less than 1y ear of age worldwide. It is usually a mild disease, but some children may develop severe symptoms, requiring hospital admission and ventilatory support in the ICU. Infants with pre-existing risk factors (prematurity, bronchopulmonary dysplasia, congenital heart diseases and immunodeficiency) may be predisposed to a severe form of the disease. Clinical diagnosis of bronchiolitis is manly based on medical history and physical examination (rhinorrhea, cough, crackles, wheezing and signs of respiratory distress). Etiological diagnosis, with antigen or genome detection to identify viruses involved, may have a role in reducing hospital transmission of the infection. Criteria for hospitalization include low oxygen saturation (
- Full Text
- View/download PDF